MISYS ANNOUNCES PRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAY 2007

• The turnaround programme is progressing in line with our expectations and the strategy outlined in March this year
  • With the appointment of our new CTO and our General Manager of Open Source, the senior management team is now complete;
  • We are now investing to grow our global services business; and
  • The cost take out programme is progressing on schedule

• Banking – improved performance and some margin recovery
  • Treasury & Capital Markets – over 20 new name wins; investing for growth
  • Core Banking – strong recurring revenues; Misys BankFusion on track

• Healthcare – realigning organisation to better execute strategy
  • Order intake and revenue growth remain poor, action being taken to improve performance
  • Simplified corporate structure to one functional organisation

• Rebalancing the portfolio underway:
  • We are continuing to focus our portfolio around higher growth market segments
  • Disposal of Sesame completed in June 2007
  • Disposal of Diagnostic Information business and CPR product announced

• Like for like revenue¹: £554m increase of 1%
• Statutory operating profit: £37m (2006: £58m)
• Like for like operating profit²: £83m increase of 17%
• Earnings per share: Basic 3.1p (2006: 44.0p); Adjusted basic³ 14.6p (2006: 14.3p)
• Full year dividend: 7.53p, up 5%

Mike Lawrie, Chief Executive, commented:

“We have a strategy in place to turn Misys around and deliver improved returns to shareholders. Revenue is flat and this is largely consistent with first half results, but our cost take out work is proceeding to plan and this is helping to drive increased profitability. 

Operationally our Treasury & Capital Markets and Core Banking businesses are making progress, particularly with our work around Misys BankFusion, but we still have much to do. 

In Healthcare performance remains poor and we are taking action to address that. Our core competence is in the ambulatory and connected community market and we have re-aligned the organisation so we can target our resources on the higher growth areas. The disposal of our hospital businesses that we announced demonstrate that we are determined to take the tough actions necessary to get focused and deliver increased shareholder value.

Our strategy is in place, the new senior management team is in place and now execution is the next critical step.”

ANALYST / INVESTOR ENQUIRIES

Alex Dee   
Tel:   +44 (0) 20 7368 2336
Mob: +44 (0) 7989 017 979
Email: alex.dee@misys.com

MEDIA ENQUIRIES

Josh Rosenstock
Tel:   +44 (0) 20 7368 2327
Mob: +44 (0) 7921 910 914
Email: josh.rosenstock@misys.com

Misys plc (FTSE: MSY.L), the global software and solutions company, is one of the world's largest and longest-established providers of industry-specific software. Founded in 1979, Misys serves the international banking and healthcare industries, combining technological expertise with in depth understanding of customers' markets and operational needs. In banking and treasury & capital markets Misys is a market leader, with over 1,200 customers, including all of the world’s top 50 banks.  In healthcare Misys is also a leader, serving more than 110,000 physicians in 18,000 practice locations, 1,200 hospitals and 600 home care providers. Misys employs around 5,500 people who serve customers in more than 120 countries. For more information, visit: www.misys.com.
 

¹        Excludes the impact of acquisitions and disposals and is stated at constant exchange rates

²     Excludes exceptional items, gains and losses on embedded derivatives, amortisation of acquired intangibles, the impact of acquisitions and disposals and is stated at constant exchange rates.

³        Excludes exceptional items, gains and losses on embedded derivatives, amortisation of acquired intangibles and exchange gains and losses on debt previously hedging goodwill written off to reserves.